Rinn Advanced Therapies

Rinn Advanced Therapies is focused on the development and manufacturing of personalised advanced cellular immune therapeutics (ACITs). Rinn Advanced Therapies is patient, and society, focused and addresses these challenges by enabling ‘personalised quality by design’ – delivering the right therapy, at the right dose, to the right patient, at the right time.

Directors: Professor Athanasios Mantalaris and Professor Owen Smith, Trinity College Dublin

Radical collaboration with: Maynooth University, National Institute for Bioprocessing Research and Training, RCSI University of Medicine and Health Sciences, Trinity College Dublin, Technological University Dublin, University College Cork, University College Dublin, University of Galway.